Nuclear Medicine Technology and Other Health Applications Project Title: Metabolism of Carbon Labeled Compounds L6. Technical Progress in FY 1973: (Contd) RxX-01-03- (e) studies of the American Negro and African Bantu. Some subjects were given 400 mg doses of carbon-14 labeled Irkynurenine and the study requires several more subjects receiving 200 mg doses. Observations reported last year suggest that South African pellagrins have subnormal vitamin Bg coenzyme levels in addition to the previously proposed stress-induced increase in the activity of tryptophan pyrrolase or a lack of feedback control of this enzyme by low pyridine nucleotides. A grant (strongly recommended by the Japanese-American Study Commission) has been obtained from the DHEW to provide two technicians to continue this internationally important project. In 1972 a iimited number of pellagra patients were studied during the pellagra season in SouthAfrica. At the request of Dr. Roux, President, and Dr. Jansen, Head of the Life Sciences Division, SAAEB, the study will be completed in 1973 with travel and laboratory expenses paid by SAAEB. In addition, patients with primary hepatoma will aiso be studied. This hepatoma is nutritionally based, causes death within three months, and has a mortality rate of more than 150 per hundred thousand per year among the Bantu. A BNL research collaborator, Dr..Ludwig Feinendegen, Director of The Institut for Medicine, KFA, Julich, Germany, has requested a week's visit by the Principal Investigator to set up a collaborative study at Julich utilizing double labeled tryptophan. 17. . (Hankes) Expected Results in FY 1974; Due to the resignation of the Principal Investigator on carbohydrate and lipid metabolism to accept a position as Head, Nuclear Medicine, Veterans Administration Hospital, Northport, New York, this area of the medical research program will be phased out. During the fiscal year, there will be continuing expenses in order to complete the clinical responsibilities to patients participating in the study. (Shreeve) Work on the mechanism of formation of the 8-methyl ether of xanthurenic ‘acid in humans is planned. Before conclusive statements can be made con ing mechanisms, studies of enzyme methylation reactions forming me kynurenine and methoxyanthranilic acid are required. Difficulties in { Mining fresh human autopsy material may delay completion of this pro > The relationship of these xanthurenic acid compounds to insulin and its control of carbohydrates will be investigated by Dr. de Bruin. Additional compounds will be prepared, resolved and standardized for further studies of pellagra, scurvy and hepatic cancer patients in South Africa and malaria patients at Stateville Prison in Illinois. (See Continuation Sheet) RX-85 1119243 A ani